BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
20.02.25
/
50%
€68.34
Target price
20.02.26
€98.56
Performance (%)
-21.69%
End price
21.02.26
€53.52
Summary
This prediction ended on 21.02.26 with a price of €53.52. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.69%. Bank_of_America_Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% | -3.367% | -7.518% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Bank of America Co. from $99.00 to $103.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.12
11.03.26
11.03.26
€73.15
11.03.27
11.03.27
-10.78%
10.04.26
10.04.26
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€103.34
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25